The role of haematological factors in diabetic peripheral arterial disease: the Edinburgh Artery Study
Amanda J. Lee
Wolfson Unit for Prevention of Peripheral Vascular Diseases, Department of Public Health Sciences, University of Edinburgh, Edinburgh,
Search for more papers by this authorAndrew S. MacGregor
Wolfson Unit for Prevention of Peripheral Vascular Diseases, Department of Public Health Sciences, University of Edinburgh, Edinburgh,
Search for more papers by this authorCathryn M. Hau
Wolfson Unit for Prevention of Peripheral Vascular Diseases, Department of Public Health Sciences, University of Edinburgh, Edinburgh,
Search for more papers by this authorJacqueline F. Price
Wolfson Unit for Prevention of Peripheral Vascular Diseases, Department of Public Health Sciences, University of Edinburgh, Edinburgh,
Search for more papers by this authorAnn Rumley
Haemostasis, Thrombosis and Vascular Medicine Unit, Department of Medicine, University of Glasgow, Glasgow Royal Infirmary, Glasgow
Search for more papers by this authorGordon D. O. Lowe
Haemostasis, Thrombosis and Vascular Medicine Unit, Department of Medicine, University of Glasgow, Glasgow Royal Infirmary, Glasgow
Search for more papers by this authorF. Gerald R. Fowkes
Wolfson Unit for Prevention of Peripheral Vascular Diseases, Department of Public Health Sciences, University of Edinburgh, Edinburgh,
Search for more papers by this authorAmanda J. Lee
Wolfson Unit for Prevention of Peripheral Vascular Diseases, Department of Public Health Sciences, University of Edinburgh, Edinburgh,
Search for more papers by this authorAndrew S. MacGregor
Wolfson Unit for Prevention of Peripheral Vascular Diseases, Department of Public Health Sciences, University of Edinburgh, Edinburgh,
Search for more papers by this authorCathryn M. Hau
Wolfson Unit for Prevention of Peripheral Vascular Diseases, Department of Public Health Sciences, University of Edinburgh, Edinburgh,
Search for more papers by this authorJacqueline F. Price
Wolfson Unit for Prevention of Peripheral Vascular Diseases, Department of Public Health Sciences, University of Edinburgh, Edinburgh,
Search for more papers by this authorAnn Rumley
Haemostasis, Thrombosis and Vascular Medicine Unit, Department of Medicine, University of Glasgow, Glasgow Royal Infirmary, Glasgow
Search for more papers by this authorGordon D. O. Lowe
Haemostasis, Thrombosis and Vascular Medicine Unit, Department of Medicine, University of Glasgow, Glasgow Royal Infirmary, Glasgow
Search for more papers by this authorF. Gerald R. Fowkes
Wolfson Unit for Prevention of Peripheral Vascular Diseases, Department of Public Health Sciences, University of Edinburgh, Edinburgh,
Search for more papers by this authorAbstract
The relationship between haematological factors and peripheral arterial disease (PAD) among diabetics has not been widely examined. 1592 men and women aged 55–74 years were selected from the general population. They underwent an assessment for PAD and a glucose tolerance test. 288 subjects (18.7%) were identified as having diabetes or impaired glucose tolerance (IGT). Among the diabetes/IGT group, median levels of fibrinogen, von Willebrand factor (VWF), tissue plasminogen activator (t-PA), fibrin D-dimer and plasma viscosity were higher in subjects with PAD than those without PAD (P ≤ 0.05). The prevalence of PAD was higher in those with diabetes/IGT (20.6%) compared to those with normal glucose tolerance (12.5%) (odds ratio 1.64; 95% CI 1.17, 2.31). After separate adjustment for fibrinogen, VWF, t-PA, fibrin D-dimer, leucocyte elastase, plasma viscosity and haematocrit, those with diabetes/IGT no longer had a significantly higher risk of PAD compared to those with a normal glucose tolerance test. Simultaneous adjustment for the first four of these haematological factors reduced the risk of PAD among subjects with diabetes/IGT to 1.11 (95% CI 0.76, 1.63). Increased levels of haemostatic factors may partly explain the higher prevalence of PAD in diabetic/IGT subjects compared to normal glucose-tolerant subjects. Future randomized controlled trials involving the indirect lowering of levels of haematological factors should help to explain whether the associations reported here are of causal significance.
References
- 1 Al Zahrani, A.H., Al Bar, H.M.S., Bahnassi, A. & Abdulaal, A.A. (1997) The distribution of peripheral arterial disease in a defined population of elderly high-risk Saudi patients. International Angiology, 16, 123–128.
- 2 Bell, D.S.H. (1997) Diabetes mellitus and coronary artery disease. Journal of Cardiovascular Risk, 4, 83–90.
- 3 Breddin, H.K., Krzywanek, H.J., Althoff, P., Kirchmaier, C.M., Rosak, C., Schepping, M., Weichert, W., Ziemen, M., Schoffling, K. & Uberla, K. (1986) Spontaneous platelet aggregation and coagulation parameters as risk factors for arterial occlusions in diabetics: results of the PARD study. International Angiology, 5, 181–195.
- 4 Bruno, G., Cavallo-Perin, P., Bargero, G., Borra, M., D'Errico, N. & Pagano, G. (1996) Association of fibrinogen with glycemic control and albumin excretion rate in patients with non-insulin-dependent diabetes mellitus. Annals of Internal Medicine, 125, 653–657.
- 5 Chandler, W.L., Alessi, M.C., Aillaud, M.F., Henderson, P., Vague, P. & Juhan-Vague, I. (1997) Clearance of tissue plasminogen activator (TPA) and TPA/plasminogen activator inhibitor type 1 (PAI-1) complex: relationship to elevated TPA antigen in patients with high PAI-1 activity levels. Circulation, 96, 761–768.
- 6 Everhart, J.E., Pettitt, D.J., Knowler, W.C., Rose, F.A. & Bennett, P.H. (1988) Medial arterial calcification and its association with mortality and complications of diabetes. Diabetologia, 31, 16–23.
- 7 Feskens, E.J.M. & Kromhout, D. (1992) Glucose tolerance and the risk of cardiovascular diseases: the Zutphen Study. Journal of Clinical Epidemiology, 45, 1327–1334.DOI: 10.1016/0895-4356(92)90173-K
- 8 Fowkes, F.G.R. (1988) The measurement of atherosclerotic peripheral arterial disease in epidemiological surveys. International Journal of Epidemiology, 17, 248–254.
- 9 Fowkes, F.G.R., Housley, E., Cawood, E.H.H., MacIntyre, C.C.A., Ruckley, C.V. & Prescott, R.J. (1991) Edinburgh Artery Study: prevalence of asymptomatic and symptomatic peripheral arterial disease in the general population. International Journal of Epidemiology 20, 384–392.
- 10 Fuller, J.H., Shipley, M.J., Rose, G., Jarrett, R.J. & Keen, H. (1983) Mortality from coronary heart disease and stroke in relation to degree of glycaemia: the Whitehall Study. British Medical Journal, 287, 867–870.
- 11 Garcia, M., McNamara, P.M., Gordon, T. & Kannel, W.B. (1974) Morbidity and mortality in diabetics in the Framingham population: sixteen-year follow-up study. Diabetes, 23, 105–111.
- 12 Godsland, I.F. & Stevenson, J.C. (1995) Insulin resistance: syndrome or tendency? Lancet, 346, 100–103.DOI: 10.1016/S0140-6736(95)92118-4
- 13 Greer, I.A., Haddad, N.G., Dawes, J., Johnstone, F.D. & Calder, A.A. (1989) Neutrophil activation in pregnancy-induced hypertension. British Journal of Obstetrics and Gynaecology, 96, 978–982.
- 14 Herman, J.B., Medalie, J.H. & Goldbourt, U. (1977) Differences in cardiovascular morbidity and mortality between previously known and newly-diagnosed adult diabetics. Diabetologia, 13, 229–234.
- 15 Janka, H.U., Standl, E. & Mehnert, H. (1980) Peripheral vascular disease in diabetes mellitus and its relation to cardiovascular risk factors: screening with the Doppler ultrasound technique. Diabetes Care, 3, 207–213.
- 16 Jarrett, R.J. (1991) Diabetes mellitus. Epidemiology of Peripheral Vascular Disease (ed. by F. G. R. Fowkes), pp. 187–193. Springer, Berlin.
- 17 Kannel, W.B., D'Agostino, R.B., Wilson, P.W.F., Belanger, A.J. & Gagnon, D.R. (1990) Diabetes, fibrinogen, and risk of cardio-vascular disease: the Framingham experience. American Heart Journal, 120, 672–676.DOI: 10.1016/0002-8703(90)90026-T
- 18 Kannel, W.B., Hjortland, M. & Castelli, W.P. (1974) Role of diabetes in congestive heart failure: the Framingham Study. American Journal of Cardiology, 34, 29–34.DOI: 10.1016/0002-9149(74)90089-7
- 19 Kannel, W.B. & McGee, D.L. (1979) Diabetes and cardiovascular disease. Journal of the American Medical Association, 241, 2035–2038.DOI: 10.1001/jama.241.19.2035
- 20 Lee, A.J., Mowbray, P.I., Lowe, G.D.O., Rumley, A., Fowkes, F.G.R. & Allan, P.A. (1998) Blood viscosity and elevated carotid intima-media thickness in men and women: the Edinburgh Artery Study. Circulation, 97, 1467–1473.
- 21 Leng, G.C. & Fowkes, F.G.R. (1992) The Edinburgh claudication questionnaire: an improved version of the WHO/Rose questionnaire for use in epidemiological surveys. Journal of Clinical Epidemiology, 45, 1101–1109.DOI: 10.1016/0895-4356(92)90150-L
- 22 Leng, G.C., Lee, A.J., Fowkes, F.G.R., Whiteman, M., Dunbar, J., Housley, E. & Ruckley, C.V. (1996) Incidence, natural history and cardiovascular events in symptomatic and asymptomatic peripheral arterial disease in the general population. International Journal of Epidemiology, 25, 1172–1181.
- 23 Lowe, G.D.O. (1991) Blood rheology. Epidemiology of Peripheral Vascular Disease (ed. by F. G. R. Fowkes), pp. 285–298. Springer, Berlin.
- 24 Lowe, G.D.O., Fowkes, F.G.R., Dawes, J., Donnan, P.T., Lennie, S.E. & Housley, E. (1993) Blood viscosity, fibrinogen, and activation of coagulation and leukocytes in peripheral arterial disease and the normal population in the Edinburgh Artery Study. Circulation, 87, 1915–1920.
- 25 Lowe, G.D.O, Smith, W.C.S., Tunstall-Pedoe, H., Crombie, I.K., Lennie, S.E., Anderson, J. & Barbanel, J.C. (1988) Cardiovascular risk and hemorheology: results from the Scottish Heart Health Study and the Monica Project, Glasgow. Clinical Hemorheology, 8, 517–524.
- 26 MacGregor, A.S., Price, J.F., Hau, C.M., Lee, A.J., Carson, M.N. & Fowkes, F.G.R. (1999) The role of systolic blood pressure and plasma triglycerides in diabetic peripheral arterial disease: the Edinburgh Artery Study. Diabetes Care, in press.
- 27 Mackaay, A.J.C., Beks, P.J., Dur, A.H.M., Bischoff, M., Scholma, J., Heine, R.J. & Rauwerda, J.A. (1995) The distribution of peripheral vascular disease in a Dutch Caucasian population: comparison of type II diabetic and non-diabetic subjects. European Journal of Vascular and Endovascular Surgery, 9, 170–175.
- 28 Maser, R.E., Wolfson, S.K., Ellis, D., Stein, E.A., Drash, A.L., Becker, D.J., Dorman, J.S. & Orchard, T.J. (1991) Cardiovascular disease and arterial calcification in insulin-dependent diabetes mellitus: interrelations and risk factor profiles. Arteriosclerosis and Thrombosis, 11, 958–965.
- 29 Mehler, P.S., Jeffers, W.J., Estacio, R. & Schrier, R.W. (1997) Associations of hypertension and complications in non-insulin-dependent diabetes mellitus. American Journal of Hypertension, 10, 152–161.DOI: 10.1016/S0895-7061(96)00344-5
- 30 Murabito, J.M., D'Agostino, R.B., Silbershatz, H. & Wilson, P.W.F. (1997) Intermittent claudication: a risk profile from the Framingham Heart Study. Circulation, 96, 44–49.
- 31 Nelson, R.G., Gohdes, D.M., Everhart, J.E., Hartner, J.A., Zwemer, F.L., Pettitt, D.J. & Knowler, W.C. (1988) Lower extremity amputations in NIDDM: 12-year follow-up study in Pima Indians. Diabetes Care, 11, 8–16.
- 32 Nilsson, S.E., Nilsson, J.E., Frostber, N. & Emilsson, T. (1967) The Kristianstad survey. II. Acta Medica Scandinavica, 469, (Suppl.), 1–42.
- 33 Orchard, T.J., Dorman, J.S., Maser, R.E., Becker, D.J., Ellis, D., LaPorte, R.E., Kuller, L.H., Wolson, S.K. & Drash, A.L. (1990) Factors associated with avoidance of severe complications after 25 years of IDDM: Pittsburgh Epidemiology of Diabetes Complications Study. I. Diabetes Care, 13, 741–747.
- 34 Paisley, R.B., Arredondo, G., Villalobos, A., Lozano, O., Guevara, L. & Kelly, S. (1984) Association of differing dietary, metabolic and clinical risk factors with macrovascular complications of diabetes: a prevalence study of 503 Mexican type II diabetic subjects. Diabetes Care, 7, 421–427.
- 35 Rose, G.A. (1962) The diagnosis of ischaemic heart pain and intermittent claudication in field surveys. Bulletin of the World Health Organization, 27, 645–658.
- 36 Standl, E., Balletshofer, B., Dahl, B., Weichmenhain, B., Stiegler, H., Hormann, A. & Holle, R. (1996) Predictors of 10-year macrovascular and overall mortality in patients with NIDDM: the Munich General Practitioner Project. Diabetologia, 39, 1540–1545.DOI: 10.1007/s001250050612
- 37 Tkac, I. & Molcanyiova, A. (1997) Fibrinogen and albuminuria are related to the presence and severity of peripheral arterial disease in women with type 2 diabetes mellitus. Angiology, 48, 715–719.
- 38 Tkac, I., Tkacova, R., Takac, M. & Lazur, J. (1992) Hematologic changes in type 2 diabetic patients with various localizations of peripheral vascular disease. Vasa, 21, 360–364.
- 39 Uusitupa, M., Siitonen, O., Aro, A. & Pyorala, K. (1985) Prevalence of coronary heart disease, left ventricular failure and hypertension in middle-aged newly diagnosed type 2 (non-insulin dependent) diabetic subjects. Diabetologia, 28, 22–27.DOI: 10.1007/BF00276995
- 40 Uusitupa, M.I.J., Niskanen, L.K., Siitonen, O., Voutilainen, E. & Pyorala, K. (1990) 5-year incidence of atherosclerotic vascular disease in relation to general risk factors, insulin level, and abnormalities in lipoprotein composition in non-insulin dependent diabetic and non-diabetic subjects. Circulation, 82, 27–36.
- 41 Walters, D.P., Gatling, W., Mullee, M.A. & Hill, R.D. (1992) The prevalence, detection, and epidemiological correlates of peripheral vascular disease: a comparison of diabetic and non-diabetic subjects in an English community. Diabetic Medicine, 9, 710–715.
- 42 World Health Organization (1980) Diabetes mellitus; report of a W.H.O. Study Group. WHO Tech. Rep. Ser. No. 727, Geneva.